Previous studies have shown that patterns of PD-L1 expression and CD8+ TIL infiltration are associated with different pathological features and clinical outcomes in various cancers, such as gastric adenocarcinomas [10], colorectal cancer [11], hepatocellular carcinoma [12] and urothelial carcinoma [13]. Here, CD274 is linked to hepatocellular carcinoma.